Achieve Life Sciences Inc

Research Achieve Life Sciences Inc (ACHV) on Bullrun: market cap USD 639.57M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerACHV
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 639.57M
• Financial periodFY2025
• Net income-USD 54.65M
• Free cash flow-USD 49.47M

Valuation Snapshot

latest market cap is USD 639.57M.

About Achieve Life Sciences Inc

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

Frequently asked questions

What is Achieve Life Sciences Inc's market cap?

Achieve Life Sciences Inc's market capitalization is USD 639.57M.

What does Achieve Life Sciences Inc do?

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.